Evidence map›Paper›PMID 36363800›Full record

ArticleMicroorganisms2022

Lipoproteins Are Potent Activators of Nuclear Factor Kappa B in Mammary Epithelial Cells and Virulence Factors in

Peleg Schneider, Re'ella Brill, Iftach Schouten, Einat Nissim-Eliraz, Inna Lysnyansky, Nahum Yehuda Shpigel

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Fenofibrate suppressesFrontiers in cellular and infection microbiology · 2025
    Article
  4. NovelFrontiers in immunology · 2025
    Article
  5. Article
  6. Review
  7. Frontiers in veterinary science · 2024
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Peleg SchneiderThe Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 76100, Israel.
Re'ella BrillThe Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 76100, Israel.
Iftach SchoutenThe Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 76100, Israel.
Einat Nissim-ElirazThe Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 76100, Israel.
Inna LysnyanskyMycoplasma Unit, Kimron Veterinary Institute, Bet Dagan 50250, Israel.ORCID 0000-0002-6923-3676
Nahum Yehuda ShpigelThe Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 76100, Israel.ORCID 0000-0003-2560-3783
Hebrew University of Jerusalem · IL

Funding

Chief Scientist, Ministry of Agriculture and Rural Development 33-08-0006Israeli Dairy Board 847-0384
6 · The paper itself

Abstract

Mastitis due to

Indexed as

immunomodulationlipoproteinsmastitismurine modelMycoplasma bovis

Identifiers

PMID36363800
PMCPMC9693531
OpenAlexW4308523194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.